2001
Hormone replacement therapy and reduced cognitive decline in older women
Carlson M, Zandi P, Plassman B, Tschanz J, Welsh-Bohmer K, Steffens D, Bastian L, Mehta K, Breitner J. Hormone replacement therapy and reduced cognitive decline in older women. Neurology 2001, 57: 2210-2216. PMID: 11756599, DOI: 10.1212/wnl.57.12.2210.Peer-Reviewed Original ResearchConceptsHormone replacement therapyModified Mini-Mental State ExaminationMMSE scoresReplacement therapyHealth QuestionnaireOlder womenPostmenopausal hormone replacement therapySelf-perceived general healthHealthy lifestyleMini-Mental State ExaminationWomen's Health QuestionnairePresence of apoERecency of exposureGlobal cognitive changeHRT exposureHRT usersHRT useIncident dementiaCalcium supplementsAPOE epsilon4General healthAPOE genotypeChronic diseasesBaseline interviewState Examination
1999
Osteoporosis risk factors: association with use of hormone replacement therapy and with worry about osteoporosis
Osborn B, Couchman G, Siegler I, Bastian L. Osteoporosis risk factors: association with use of hormone replacement therapy and with worry about osteoporosis. Women's Health Issues 1999, 9: 278-285. DOI: 10.1016/s1049-3867(99)00017-1.Peer-Reviewed Original ResearchHormone replacement therapyRisk of osteoporosisRisk factorsPostmenopausal womenFamily historyHRT useReplacement therapyWhite raceBenefits of HRTSelf-rated current healthHormone replacement therapy useOnly risk factorComprehensive health centersLogistic regression analysisDiagnosis of osteoporosisCross-sectional surveyChi-square testTherapy usePatient awarenessHealth centersMedical conditionsWomen veteransOsteoporosisAge 60Current health
1998
Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Primary Care Update For OB/GYNS 1998, 5: 165. PMID: 10838309, DOI: 10.1016/s1068-607x(98)00064-x.Peer-Reviewed Original ResearchHormone replacement therapySummary relative riskRectal cancer incidenceHRT usersColon cancerReplacement therapyCancer incidenceRelative riskUse of HRTRisk estimatesPostmenopausal HRT usersRetrievable risk estimatesColorectal cancer incidenceAdjusted risk estimatesColon cancer mortalityRisk of deathMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language studiesTime of assessmentEstrogen usersHRT usePromoting Informed Decision Making: Hormone Replacement Therapy
Bastian L, Couchman G, Rimer B, McBride C, Sutton L, Siegler I. Promoting Informed Decision Making: Hormone Replacement Therapy. Cancer Treatment And Research 1998, 97: 129-147. PMID: 9711414, DOI: 10.1007/978-0-585-30498-4_10.Peer-Reviewed Original ResearchConceptsHormonal replacement therapyReplacement therapyBreast cancerHormone replacement therapyRisk of cancerHRT useMenopausal symptomsMost gynecologistsHeart diseaseHigh riskNumber of womenAverage life expectancyCancerCancer issuesLife expectancyWomenMenopausePatientsTherapyRiskOsteoporosisGynecologistsSymptomsDiseasePhysicians
1997
Perceptions of Menopausal Stage and Patterns of Hormone Replacement Therapy Use
Bastian L, Couchman G, Rimer B, McBride C, Feaganes J, Siegler I. Perceptions of Menopausal Stage and Patterns of Hormone Replacement Therapy Use. Journal Of Women's Health 1997, 6: 467-475. PMID: 9279835, DOI: 10.1089/jwh.1997.6.467.Peer-Reviewed Original ResearchConceptsHormone replacement therapyUse of HRTHRT useStage of menopauseMenopausal stagePatient characteristicsHormone replacement therapy useCohort of womenWomen's perceptionsLogistic regression modelsBilateral oophorectomyMenopausal statusIndependent predictorsTherapy useReplacement therapyPelvic examinationOvarian cancerBreast cancerFamily historyMenopauseAverage agePhysical exerciseYoung womenWomenOverall rate